Ambry CancerNext Expanded
Synonyms |
|
||||||||||||||||||||
Cerner Name |
|||||||||||||||||||||
Clinical Info |
Comprehensive, pan-cancer test for hereditary cancer predisposition, including genes associated with a wide range of hereditary cancers such as breast, ovarian, uterine, colorectal, gastric, pancreatic, prostate, melanoma, renal, central nervous system tumors, pheochromocytoma/paraganglioma, hematologic malignancy, and other rare cancer predisposition conditions. 77 genes are included in the analysis: AIP, ALK, APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CEBPA, CHEK2, CTNNA1, DDX41, DICER1, EGFR, EPCAM, ETV6, FH, FLCN, GATA2, GREM1, HOXB13, KIT, LZTR1, MAX, MBD4, MEN1, MET, MITF, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NF2, NTHL1, PALB2, PDGFRA, PHOX2B, PMS2, POLD1, POLE, POT1, PRKAR1A, PTCH1, PTEN, RAD51C, RAD51D, RB1, RET, RPS20, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4, SMARCB1, SMARCE1, STK11, SUFU, TMEM127, TP53, TSC1, TSC2, VHL, WT1 |
||||||||||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous Buccal |
||||||||||||||||||||
Specimen Types |
Blood Swab |
||||||||||||||||||||
Specimen Volume |
4mL |
||||||||||||||||||||
Container |
Lavender Top Tube (EDTA whole blood) or Buccal Swab |
||||||||||||||||||||
Collection Instructions |
Whole Blood |
||||||||||||||||||||
Transport Instructions |
Room Temperature |
||||||||||||||||||||
Specimen Stability |
|
||||||||||||||||||||
Methodology |
Next Generation Sequencing (NGS) |
||||||||||||||||||||
Days Performed |
Monday-Saturday |
||||||||||||||||||||
Performing Laboratories |
|
||||||||||||||||||||
CPT |
81432 or 81435 |
||||||||||||||||||||
PDM |
255308 |
||||||||||||||||||||
Results |
|
||||||||||||||||||||
Result InterpretationSee Report |
|||||||||||||||||||||
Forms |
|
||||||||||||||||||||